论文部分内容阅读
目的:探讨盐酸氨溴索加盐酸丙特罗治疗小儿肺炎的临床疗效。方法:选取2014年3月-2016年3月在我院接受治疗的肺炎患儿106例,其中53例患儿采用常规方法进行治疗(对照组),另外53例患者在常规治疗基础上采用盐酸氨溴索加盐酸丙特罗进行治疗,观察并比较两组的治疗效果。结果:观察组治疗总有效率为88.7%,明显高于对照组的73.5%,P<0.05,有统计学意义;观察组患儿退热时间、喘息消退时间、咳嗽消退时间、肺部罗音消退时间均明显短于对照组,P<0.05,有统计学意义。结论:盐酸氨溴索加盐酸丙特罗治疗小儿肺炎疗效明显优于常规治疗,可有效改善患儿的临床症状。
Objective: To investigate the clinical efficacy of ambroxol hydrochloride and phenaceroside in the treatment of children pneumonia. Methods: A total of 106 children with pneumonia who were treated in our hospital from March 2014 to March 2016 were selected, of whom 53 were treated by conventional methods (control group). Another 53 patients were treated with hydrochloric acid Ambroxol hydrochloride and pirozole treatment, observation and comparison of the two groups of treatment. Results: The total effective rate of the observation group was 88.7%, significantly higher than that of the control group (73.5%, P <0.05), and the difference was statistically significant. The observation group had better effects of antipyretic time, wheezing subsided time, cough subsidence time, The regression time was significantly shorter than the control group, P <0.05, with statistical significance. CONCLUSION: Ambroxol hydrochloride plus propoxol hydrochloride is superior to routine treatment in children with pneumonia, which can effectively improve the clinical symptoms of children.